Literature DB >> 1615132

Subjective and behavioral responses to intravenous fentanyl in healthy volunteers.

J P Zacny1, J L Lichtor, J G Zaragoza, H de Wit.   

Abstract

Fentanyl is a mu opiate agonist which is occasionally abused by medical personnel who have ready access to the drug. We examined in healthy volunteers (N = 13) the subjective and psychomotor-impairing effects of intravenous fentanyl (0-100 micrograms/70 kg). A randomized, placebo-controlled, crossover design was used in which subjects were injected with 0, 25 (N = 6), 50 and 100 micrograms/70 kg fentanyl in a double-blind fashion. Subjects completed several questionnaires commonly used in abuse liability testing studies before drug injection and at periodic intervals for up to 3 h after drug injection. Subjects also completed several psychomotor tests at these times. Some aspects of psychomotor functioning (e.g., eye-hand coordination) were impaired by fentanyl. Fentanyl produced dose-related increases in ratings of "high" and "sedated," but also tended to produce dysphoria and somatic symptomatology. Most subjects reported liking the effects of the two higher doses of fentanyl for at least a brief time after injection, but they varied widely in their linking ratings across the 3-h post-drug injection period. Despite the transient increases in liking ratings, fentanyl did not increase scores on a widely-used measure of drug-induced euphoria (morphine-benzedrine group scale of the Addiction Research Center Inventory). The present results suggest that some medical personnel who experiment with fentanyl may like it, and thus be at increased risk for abusing the drug in the future.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1615132     DOI: 10.1007/bf02245155

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  35 in total

1.  Comparison of psychological effects of certain centrally acting drugs in man.

Authors:  C KORNETSKY; O HUMPHRIES; E V EVARTS
Journal:  AMA Arch Neurol Psychiatry       Date:  1957-03

2.  Ventilatory and mental effects of alfentanil and fentanyl.

Authors:  F L Scamman; M M Ghoneim; K Korttila
Journal:  Acta Anaesthesiol Scand       Date:  1984-02       Impact factor: 2.105

3.  Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II.

Authors:  K C Kirby; M L Stitzer; S J Heishman
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

4.  Psychomotor performance of patients with rheumatoid arthritis: cross-over comparison of dextropropoxyphene, dextropropoxyphene plus amitriptyline, indomethacin, and placebo.

Authors:  U Saarialho-Kere; H Julkunen; M J Mattila; T Seppälä
Journal:  Pharmacol Toxicol       Date:  1988-10

5.  Psychomotor, respiratory and neuroendocrinological effects of a mu-opioid receptor agonist (oxycodone) in healthy volunteers.

Authors:  U Saarialho-Kere; M J Mattila; T Seppälä
Journal:  Pharmacol Toxicol       Date:  1989-10

6.  Assessment of dezocine for morphine-like subjective effects and miosis.

Authors:  D R Jasinski; K L Preston
Journal:  Clin Pharmacol Ther       Date:  1985-11       Impact factor: 6.875

7.  Measurement of recovery from outpatient general anaesthesia with a simple ocular test.

Authors:  J G Hannington-Kiff
Journal:  Br Med J       Date:  1970-07-18

8.  Morphine, experimental pain, and psychological reactions.

Authors:  L F Jarvik; J H Simpson; D Guthrie; E H Liston
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  Affinities of some common opioid analgesics towards four binding sites in mouse brain.

Authors:  A Neil
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-11       Impact factor: 3.000

10.  Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients, and postaddicts.

Authors:  L LASAGNA; J M VON FELSINGER; H K BEECHER
Journal:  J Am Med Assoc       Date:  1955-03-19
View more
  15 in total

1.  The response to rapid infusion of fentanyl in the human brain measured using pulsed arterial spin labelling.

Authors:  Fernando O Zelaya; Evangelos Zois; Christopher Muller-Pollard; David J Lythgoe; Sarah Lee; Caroline Andrews; Trevor Smart; Patricia Conrod; William Vennart; Steven C R Williams; Mitul A Mehta; Laurence J Reed
Journal:  MAGMA       Date:  2011-11-24       Impact factor: 2.310

2.  A comparison of the acute behavioral effects of flunitrazepam and triazolam in healthy volunteers.

Authors:  M Farré; M T Terán; J Camí
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

3.  The prescription opioid, oxycodone, does not alter behavioral measures of impulsivity in healthy volunteers.

Authors:  James P Zacny; Harriet de Wit
Journal:  Pharmacol Biochem Behav       Date:  2009-08-04       Impact factor: 3.533

Review 4.  Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment.

Authors:  Sandra D Comer; Catherine M Cahill
Journal:  Neurosci Biobehav Rev       Date:  2018-12-05       Impact factor: 8.989

Review 5.  Do initial responses to drugs predict future use or abuse?

Authors:  Harriet de Wit; Tamara J Phillips
Journal:  Neurosci Biobehav Rev       Date:  2012-04-21       Impact factor: 8.989

6.  Subjective, behavioral and physiological responses to intravenous meperidine in healthy volunteers.

Authors:  J P Zacny; J L Lichtor; W Binstock; D W Coalson; T Cutter; D C Flemming; B Glosten
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Effects of oxycodone on brain responses to emotional images.

Authors:  Margaret C Wardle; Daniel A Fitzgerald; Michael Angstadt; Christine A Rabinak; Harriet de Wit; K Luan Phan
Journal:  Psychopharmacology (Berl)       Date:  2014-05-07       Impact factor: 4.530

8.  [Influence of changes to daily dose of opioids on aspects of cognitive and psychomotor performance involved in driving].

Authors:  J Gaertner; F Elsner; L Radbruch; F Kolibay; M Theisohn; G Berghaus; H J Gerbershagen; O Dagtekin; R Sabatowski
Journal:  Schmerz       Date:  2008-08       Impact factor: 1.107

9.  Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history.

Authors:  J L Azolosa; M L Stitzer; M K Greenwald
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

10.  Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers.

Authors:  Sandra D Comer; Maria A Sullivan; Robert A Whittington; Suzanne K Vosburg; William J Kowalczyk
Journal:  Neuropsychopharmacology       Date:  2007-06-20       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.